DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

8.30 0.24 (2.99%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $8.30 2.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.04
Previous Close $8.06
Daily Range $8.01 - $8.36
52-Week Range $5.86 - $13.50
Market Cap $1.8B
P/E Ratio -22.39
Dividend (Yield) $0.00 (0.0%)
Volume 6,433,131
Average Daily Volume 5,273,699
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary Rss Feed

The 7 Least Obese U.S. States

A mixture of cultural and socioeconomic factors make these seven U.S. states the healthiest.

Arena - Good Sales, Bad Sales, Long And Short

First Manhattan Still Playing Hardball With Vivus

Arena Is Still A Great Short

Arena Buyout More 'Highly Probable' Than MannKind

Why Doctors Can Prescribe Arena's Belviq For Off Label Uses Without Worrying About Legal Liability

3 Pipeline Obesity Treatments You Should Watch

In the past year, two approved obesity drugs put the massive obesity market within reach of investors. Here are three treatments under development that could have even bigger consequences.

Arena Pharmaceuticals - Out To Launch Or Out To Lunch?

The Surprising Link Between ADHD and Obesity

This disorder in childhood could put your adult health at risk.

The Facebook Effect On Arena's Belviq Sales And Why It Will Ultimately Dwarf Anything Eisai Does

See More ARNA News...

ARNA's Top Competitors

ARNA $8.30 (2.99%)
Current stock: ARNA
AMGN $105.91 (0.27%)
Current stock: AMGN
GILD $55.81 (0.59%)
Current stock: GILD
BIIB $235.24 (1.13%)
Current stock: BIIB